Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AVP | ridiculous renumeration | 13/01/09 | 0 | 933 | |||
|
|||||||
AVP | ridiculous renumeration | 13/01/09 | 0 | 862 | |||
|
|||||||
AVP | avp is now gcg | 30/07/07 | 0 | 1.2K | |||
|
|||||||
AVP | extra interest today | 24/07/07 | 1 | 1.7K | |||
|
|||||||
AVP | new direction for acuron | 25/04/07 | 3 | 2.4K | |||
|
|||||||
AVP | accumulation | 13/09/06 | 11 | 3.5K | |||
|
|||||||
AVP | funny business maybe | 21/08/06 | 1 | 1.1K | |||
|
|||||||
AVP | picking off | 27/06/06 | 0 | 415 | |||
|
See All Discussions